Login Register Cart 0
Generic placeholder image

Letters in Drug Design & Discovery

Editor-in-Chief

ISSN (Print): 1570-1808
ISSN (Online): 1875-628X

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

Synthesis, Characterization and Antimicrobial Activity of Some Novel 1- substituted Benzimidazole Derivatives

Author(s): Erkut Isik, Demet Astley, Seda Yuksekdanaci* and Ihsan Yasa

Volume 17, Issue 11, 2020

Page: [1372 - 1379] Pages: 8

DOI: 10.2174/1570180817999200531164230

Price: $65

Abstract

Background: Benzimidazole derivatives are an important class of heterocyclic compounds in organic chemistry as they are related to a wide range of biological properties, including antimicrobial activity.

Methods: A series of 1-naphthoyl and benzoyl benzimidazole derivatives were synthesised, identified and screened for their antimicrobial activities against a number of different test organisms such as Escherichia coli, Pseudomonas aureginosa, Klebsiella pneumoniae, Staphylococcus aureus, Enterococcus faecalis, Bacillus cereus, Salmonella typhimurium, Candida albicans (yeast).

Results and Discussion: Benzimidazole derivatives (3a-d) were synthesised by using 4 different aminoacids. L-methionine, L-isoleucine, D-Phenylysine and L-Phenylamine as starting materials in the study. Experimental studies involve the use of benzimidazole derivatives (3a-d) of the selected amino acids to synthesize the benzoyl and naphthoyl derivatives of benzimidazole (4a-d, 5a-c). The structures of the synthesized compounds were confirmed by spectroscopic analyses (FTIR, 1HNMR, 13C-NMR) and elemental analysis.

Conclusion: In this study, only one compound (5a) showed a low MIC value against the eukaryotic microorganism C. albicans. The other six compounds showed higher antimicrobial activities against the prokaryotes C. albicans which is a normal flora in the mouth but is one of the organisms that cause infections leading to the weakening of the human immune system. Compound 5a is a candidate for future alternative antimicrobial drugs against C. albicans infections. In addition, compound 5a has a potential to be used as an inhibitor against P. aureginosa for the treatment of cystic fibrosis.

Keywords: Synthesis, chiral, benzimidazole, bacteria, antimicrobial, Minimum Inhibitory Concentration (MIC).

« Previous Next »
Graphical Abstract

[1]
Negi, D.S.; Kumar, G.; Singh, M.; Singh, N. Antibacterial activity of benzimidazole derivatives: A mini rewiev. RRJCHEM, 2017, 6, 18-28.
[2]
Al-Jorani, K.R.; Atia, A.J.; Lafta, S.J.; Al-Bayti, R.I.; Kadhem, S.A.; Baqer, S.M. Antibacterial Activity of New Benzimidazole Moiety Synthesis via a Acid chloride and Related Heterocyclic Chalcones. Journal of Pharmaceutical Sciences and Research, 2019, 11, 1195-1203.
[3]
Vinoth, K.S.; Senthilkumar, R.; Jothimanivannan, C.; Abdul, L.M.K.M.; Kiran, K. Synthesis, Characterization, In Silico prediction and Anti-microbial evalua-tion of 2-Substituted Benzimidazole Derived Mannich bases. International Journal of Research in Pharmaceutical Sciences, 2018, 9, 381-386.
[4]
Bie, F.; Liu, X.; Han, Y.; Yan, P.; Cao, H. A kind of synthetic method of the 1-benzamido group substituted benzimidazole of metal catalytic. Faming Zhuanli Shenqing, CN 109020895 A 20181218, 2018.
[5]
Pribut, N.; Basson, A.E.; van Otterlo, W.A.L.; Liotta, D.C.; Pelly, S.C. Aryl Substituted Benzimidazolones as Potent HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors. ACS Med. Chem. Lett., 2019, 10(2), 196-202.
[http://dx.doi.org/10.1021/acsmedchemlett.8b00549 PMID: 30783503]
[6]
Shaker, Y.M.; Omar, M.A.; Mahmoud, K.; Elhallouty, S.M.; El-Senousy, W.M.; Ali, M.M.; Mahmoud, A.E.; Abdel-Halim, A.H.; Soliman, S.M.; El Diwani, H.I. Synthesis, in vitro and in vivo antitumor and antiviral activity of novel 1-substituted benzimidazole derivatives. J. Enzyme Inhib. Med. Chem., 2015, 30(5), 826-845.
[http://dx.doi.org/10.3109/14756366.2014.979344 PMID: 25567722]
[7]
Budow, S.; Kozlowska, M.; Gorska, A.; Kazimierczuk, Z.; Eickmeier, H.; La Colla, P.; Gosselin, G.; Seela, F. Substituted benzimidazoles: antiviral activity and synthesis of nucleosides. ARKIVOC, 2009, 3, 225-250.
[8]
Rajamanickam, G.; Selvaraj, J.; Selvaraj, S.; Rajendran, T.; Sarker, M.R. In vitro anthelmintic and antimicrobial activity of novel series of quinoxaline- 2, 3-dione -6-sulphonyl Benzimidazole(s). Journal of Chemical and Pharmaceutical Sciences, 2015, 8, 656-660.
[9]
Himaja, M.; Sirisha, B.; Das, M.; Munirajsekhar, D. Synthesis and anthelmintic activity studies of 1-substituted benzimidazole derivatives. J. Indian Chem. Soc., 2015, 92, 908-910.
[10]
Cole, D.C.; Gross, J.L.; Comery, T.A.; Aschmies, S.; Hirst, W.D.; Kelley, C.; Kim, J.I.; Kubek, K.; Ning, X.; Platt, B.J.; Robichaud, A.J.; Solvibile, W.R.; Stock, J.R.; Tawa, G.; Williams, M.J.; Ellingboe, J.W. Benzimidazole- and indole-substituted 1,3′-bipyrrolidine benzamides as histamine H3 receptor antagonists. Bioorg. Med. Chem. Lett., 2010, 20(3), 1237-1240.
[http://dx.doi.org/10.1016/j.bmcl.2009.11.122 PMID: 20042333]
[11]
Jain, A.; Parate, A.; Sharma, R.; Chaturvedi, S.C. A rational design, synthesis, characterization, and antihypertensive activities of some new substituted benzimidazoles. Med. Chem. Res., 2013, 1, 6-19.
[http://dx.doi.org/10.1007/s00044-012-0462-7]
[12]
Kolaczkowski, M.; Bucki, A.; Sniecikowska, J.; Marcinkowska, M. Indole and benzimidazole derivatives as dual 5-HT2A and 5-HT6 receptor antagonists PCT International Application, WO 2019162306 A1 20190829., 2019.
[13]
Wang, X.J.; Xi, M.Y.; Fu, J.H.; Zhang, F.R.; Cheng, G.F.; Yin, D.L.; You, Q.D. Synthesis, biological evaluation and SAR studies of benzimidazole derivatives as H1-antihistamine agents. Chin. Chem. Lett., 2012, 23, 707-710.
[http://dx.doi.org/10.1016/j.cclet.2012.04.020]
[14]
Gowda, N.R.T.; Kavitha, C.V.; Chiruvella, K.K.; Joy, O.; Ran-gappa, K.S.; Raghavan, S.C. Synthesis and biological evaluation of novel 1-(4-methoxyphenethyl)-1H-benzimidazole-5-carboxylic acid derivatives and their precursors as antileukemic agents. Bioorg. Med. Chem. Lett., 2009, 19(16), 4594-4600.
[http://dx.doi.org/10.1016/j.bmcl.2009.06.103 PMID: 19616939]
[15]
Villa, P.; Arumugam, N.; Almansour, A.I.; Suresh Kumar, R.; Mahalingam, S.M.; Maruoka, K.; Thangamani, S. Benzimidazole tethered pyrrolo[3,4-b]quinoline with broad-spectrum activity against fungal pathogens. Bioorg. Med. Chem. Lett., 2019, 29(5), 729-733.
[http://dx.doi.org/10.1016/j.bmcl.2019.01.006 PMID: 30655213]
[16]
Imran, M. Preparation of benzimidazole based coumarin derivatives as antimicrobial and antioxidant agents. Orient. J. Chem., 2019, 35, 1392-1397.
[http://dx.doi.org/10.13005/ojc/350420]
[17]
Mistry, T.L.; Truong, L.; Ghosh, A.K.; Johnson, M.E.; Mehboob, S. Benzimidazole-based fabI inhibitors: A promising novel scaffold for anti-staphylococcal drug development. ACS Infect. Dis., 2017, 3(1), 54-61.
[http://dx.doi.org/10.1021/acsinfecdis.6b00123 PMID: 27756129]
[18]
Zhang, H.Z.; Lin, J.M.; Rasheed, S.; Zhou, C.H. Design, synthesis, and biological evaluation of novel benzimidazole derivatives and their interaction with calf thymus DNA and synergistic effects with clinical drugs. Sci. China Chem., 2014, 57, 807-822.
[http://dx.doi.org/10.1007/s11426-014-5087-x]
[19]
Puratchikody, A.; Nagalakshmi, G.; Doble, M. Experimental and QSAR studies on antimicrobial activity of benzimidazole derivatives. Chem. Pharm. Bull. (Tokyo), 2008, 56(3), 273-281.
[http://dx.doi.org/10.1248/cpb.56.273 PMID: 18310935]
[20]
Ajani, O.O.; Tolu-Bolaji, O.O.; Olorunshola, S.J.; Zhao, Y.; Aderohunmu, D.V. Structure-based design of functionalized 2-substituted and 1,2-disubstituted benzimidazole derivatives and their in vitro antibacterial efficacy. J. Adv. Res., 2017, 8(6), 703-712.
[http://dx.doi.org/10.1016/j.jare.2017.09.003 PMID: 29188079]
[21]
Korkmaz, N.; Obaidi, O.A.; Senturk, M.; Astley, D.; Ekinci, D.; Supuran, C.T. Synthesis and biological activity of novel thiourea derivatives as carbonic anhydrase inhibitors. J. Enzyme Inhib. Med. Chem., 2015, 30(1), 75-80.
[http://dx.doi.org/10.3109/14756366.2013.879656 PMID: 24666304]
[22]
Bansal, Y.; Silakari, O. The therapeutic journey of benzimidazoles: a review. Bioorg. Med. Chem., 2012, 20(21), 6208-6236.
[http://dx.doi.org/10.1016/j.bmc.2012.09.013 PMID: 23031649]
[23]
Salahuddin, S.M.; Mazumder, A. Benzimidazoles: A biologically active compounds. Arab. J. Chem., 2017, 10, 157-173.
[http://dx.doi.org/10.1016/j.arabjc.2012.07.017]
[24]
Sharma, P.; Rane, N.; Gurram, V.K. Synthesis and QSAR studies of pyrimido[4,5-d]pyrimidine-2,5-dione derivatives as potential antimicrobial agents. Bioorg. Med. Chem. Lett., 2004, 14(16), 4185-4190.
[http://dx.doi.org/10.1016/j.bmcl.2004.06.014 PMID: 15261267]
[25]
Sharma, S.; Gangal, S.; Rauf, A. Convenient one-pot synthesis of novel 2-substituted benzimidazoles, tetrahydrobenzimidazoles and imidazoles and evaluation of their in vitro antibacterial and antifungal activities. Eur. J. Med. Chem., 2009, 44(4), 1751-1757.
[http://dx.doi.org/10.1016/j.ejmech.2008.03.026 PMID: 18472189]
[26]
Yadav, S.; Lim, S.M.; Ramasamy, K.; Vasudevan, M.; Shah, S.A.A.; Mathur, A.; Narasimhan, B. Synthesis and evaluation of antimicrobial, antitubercular and anticancer activities of 2-(1-benzoyl-1H-benzo[d]imidazol-2-ylthio)-N-substituted acetamides. Chem. Cent. J., 2018, 12(1), 66.
[http://dx.doi.org/10.1186/s13065-018-0432-3 PMID: 29804151]
[27]
Tunçbilek, M.; Kiper, T.; Altanlar, N. Synthesis and in vitro antimicrobial activity of some novel substituted benzimidazole derivatives having potent activity against MRSA. Eur. J. Med. Chem., 2009, 44(3), 1024-1033.
[http://dx.doi.org/10.1016/j.ejmech.2008.06.026 PMID: 18718694]

Rights & Permissions Print Cite
Article Metrics
13
© 2024 Bentham Science Publishers | Privacy Policy